Skip to content

Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Controlled Study

Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Controlled Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07511634
Enrollment
80
Registered
2026-04-06
Start date
2026-04-01
Completion date
2026-12-31
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthesia

Keywords

Analgesia Nociception Index, ANI, Sevoflurane

Brief summary

This prospective randomized controlled study will compare the effects of sevoflurane and desflurane on the Analgesia Nociception Index (ANI) in adult patients undergoing general anesthesia. Participants will be randomized to maintenance anesthesia with either sevoflurane or desflurane, and ANI responses to a standardized nociceptive stimulus will be measured under equi-minimum alveolar concentration (age-adjusted 1.0 MAC) conditions. The primary objective is to compare the change in ANI before and after tetanic stimulation between the two anesthetic groups. Secondary measurements will include bispectral index, blood pressure, heart rate, and end-tidal anesthetic concentration around the time of stimulation.

Detailed description

This prospective randomized controlled study will compare the effects of sevoflurane and desflurane on the Analgesia Nociception Index (ANI) in adult patients undergoing general anesthesia. Conventional indicators of intraoperative nociception, such as changes in blood pressure, heart rate, and patient movement, can be influenced by anesthetic depth, vasoactive agents, and intravascular volume status. ANI is a heart rate variability-based monitoring index developed to provide a more objective assessment of nociception during general anesthesia. Previous studies have suggested that sevoflurane and desflurane may produce different nociceptive responses at equi-minimum alveolar concentration (MAC), but comparative data using ANI are lacking. In this study, eligible patients will be randomized to maintenance anesthesia with either sevoflurane or desflurane. After standardized induction and stabilization at age-adjusted 1.0 MAC, a standardized tetanic stimulation will be applied, and ANI will be recorded 1 minute before and 1 minute after stimulation. The primary objective is to compare the between-group difference in ANI change in response to the same nociceptive stimulus under equi-MAC conditions. Secondary assessments will include bispectral index, blood pressure, and heart rate measured around the time of stimulation.

Interventions

DRUGDesflurane

Desflurane will be administered for maintenance of general anesthesia after loss of consciousness following propofol induction. End-tidal desflurane concentration will be titrated to age-adjusted 1.0 MAC (±0.1 MAC) at the time of ANI assessment.

DRUGSevoflurane

Sevoflurane will be administered for maintenance of general anesthesia after loss of consciousness following propofol induction. End-tidal sevoflurane concentration will be titrated to age-adjusted 1.0 MAC (±0.1 MAC) at the time of ANI assessment.

Sponsors

Pusan National University Yangsan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

This is a randomized, parallel-group study in which participants are assigned in a 1:1 ratio to desflurane or sevoflurane maintenance anesthesia. Under age-adjusted 1.0 MAC conditions, ANI responses to standardized tetanic stimulation will be compared between groups.

Eligibility

Sex/Gender
ALL
Age
19 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 19 to 79 years * Patients undergoing general anesthesia * American Society of Anesthesiologists (ASA) physical status I or II

Exclusion criteria

* History of taking medications that may affect the central nervous system or autonomic nervous system (e.g., anticholinergics, beta-blockers, antidepressants, anxiolytics, hypnotics, or analgesics) * Known hypersensitivity to sevoflurane, desflurane, or other halogenated anesthetics, or a personal or family history of malignant hyperthermia * Neurologic or psychiatric disorders (e.g., depression, dementia, or cerebral infarction) * Arrhythmia * Diabetes mellitus * Drug abuse or alcohol abuse * Vulnerable subjects * Patients aged 80 years or older * Patients with impaired consciousness or those judged to lack the capacity to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Analgesia Nociception Index (ANI) From 1 Minute Before to 1 Minute After Tetanic StimulationFrom 1 minute before tetanic stimulation to 1 minute after tetanic stimulationANI will be measured 1 minute before and 1 minute after standardized tetanic stimulation. The primary analysis will compare the between-group difference in ANI change from before to after stimulation.

Secondary

MeasureTime frame
Bispectral Index (BIS)Before induction of anesthesia, 1 minute before tetanic stimulation, and 1 minute after tetanic stimulation
Blood PressureBefore induction of anesthesia, 1 minute before tetanic stimulation, and 1 minute after tetanic stimulation
Heart RateBefore induction of anesthesia, 1 minute before tetanic stimulation, and 1 minute after tetanic stimulation

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026